Ola Caster
Ola Caster
Pharmetheus
Verifierad e-postadress på pharmetheus.com
Titel
Citeras av
Citeras av
År
Large‐scale regression‐based pattern discovery: The example of screening the WHO global drug safety database
O Caster, GN Norén, D Madigan, A Bate
Statistical Analysis and Data Mining: The ASA Data Science Journal 3 (4 …, 2010
762010
Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®
RE Chandler, K Juhlin, J Fransson, O Caster, IR Edwards, GN Norén
Drug Safety 40 (1), 81-90, 2017
662017
The lasso—a novel method for predictive covariate model building in nonlinear mixed effects models
J Ribbing, J Nyberg, O Caster, EN Jonsson
Journal of pharmacokinetics and pharmacodynamics 34 (4), 485-517, 2007
652007
Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank
O Caster, K Juhlin, S Watson, GN Norén
Drug Safety 37 (8), 617-628, 2014
552014
Earlier discovery of pregabalin’s dependence potential might have been possible
O Caster, IR Edwards, GN Norén, M Lindquist
European journal of clinical pharmacology 67 (3), 319-320, 2011
442011
Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance
GN Norén, O Caster, K Juhlin, M Lindquist
Drug safety 37 (9), 655-659, 2014
382014
Assessment of the utility of social media for broad-ranging statistical signal detection in pharmacovigilance: results from the WEB-RADR project
O Caster, J Dietrich, ML Kürzinger, M Lerch, S Maskell, GN Norén, ...
Drug safety 41 (12), 1355-1369, 2018
262018
Reporting Patterns Indicative of Adverse Drug Interactions
J Strandell, O Caster, A Bate, N Norén, IR Edwards
Drug safety 34 (3), 253-266, 2011
252011
The development and evaluation of triage algorithms for early discovery of adverse drug interactions
J Strandell, O Caster, J Hopstadius, IR Edwards, GN Norén
Drug safety 36 (5), 371-388, 2013
212013
Reflections on attribution and decisions in pharmacovigilance
O Caster, IR Edwards
Drug safety 33 (10), 805-809, 2010
212010
Methylprednisolone-induced hepatotoxicity: experiences from global adverse drug reaction surveillance
O Caster, A Conforti, E Viola, IR Edwards
European journal of clinical pharmacology 70 (4), 501-503, 2014
192014
Logistic regression in signal detection: another piece added to the puzzle
O Caster, GN Norén, D Madigan, A Bate
Clinical pharmacology and therapeutics 94 (3), 312-312, 2013
162013
Quantitative benefit-risk assessment using only qualitative information on utilities
O Caster, GN Norén, L Ekenberg, IR Edwards
Medical Decision Making 32 (6), E1-E15, 2012
142012
vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real‐world use
O Caster, L Sandberg, T Bergvall, S Watson, GN Norén
Pharmacoepidemiology and Drug Safety 26 (8), 1006-1010, 2017
132017
Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome
YS Low, O Caster, T Bergvall, D Fourches, X Zang, GN Norén, I Rusyn, ...
Journal of the American Medical Informatics Association 23 (5), 968-978, 2016
132016
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
O Caster, IR Edwards
BMC Neurology 15 (1), 206, 2015
122015
Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century
S Watson, O Caster, PA Rochon, H den Ruijter
EClinicalMedicine 17, 100188, 2019
112019
Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a …
L Rolfes, F van Hunsel, O Caster, H Taavola, K Taxis, E van Puijenbroek
British Journal of Clinical Pharmacology 84 (7), 1514-1524, 2018
102018
Combining second-order belief distributions with qualitative statements in decision analysis
O Caster, L Ekenberg
Managing Safety of Heterogeneous Systems, 67-87, 2012
102012
Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR
J van Stekelenborg, J Ellenius, S Maskell, T Bergvall, O Caster, ...
Drug Safety 42 (12), 1393-1407, 2019
92019
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20